Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Commentary/Editorials
Commentary/Editorials
Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations
Muhammad Bilal
Abid
Journal for ImmunoTherapy of Cancer
Apr 2021,
9
(4)
e002307;
DOI:
10.1136/jitc-2020-002307
Introducing the clinical trials monitor: a new section of the journal for immunotherapy of cancer
Leisha A.
Emens
,
Pedro
Romero
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
49;
DOI:
10.1186/s40425-015-0092-y
The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer
Thaïs
Baert
,
Tina
Verschuere
,
Anaïs
Van Hoylandt
,
Rik
Gijsbers
,
Ignace
Vergote
,
An
Coosemans
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
57;
DOI:
10.1186/s40425-015-0102-0
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
Lisa H
Butterfield
,
Mary L
Disis
,
Bernard A
Fox
,
Samir N
Khleif
,
Francesco M
Marincola
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
8;
DOI:
10.1186/s40425-015-0052-6
The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
Emanuela
Romano
,
Pedro
Romero
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
15;
DOI:
10.1186/s40425-015-0059-z
JITC launches a new section: commentary and editorials
Christian M.
Capitini
,
Pedro
Romero
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
28;
DOI:
10.1186/s40425-015-0073-1
Update on checkpoint blockade therapy for lymphoma
Justin
Kline
,
Michael R.
Bishop
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
33;
DOI:
10.1186/s40425-015-0079-8
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
Stefani
Spranger
,
Thomas F.
Gajewski
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
43;
DOI:
10.1186/s40425-015-0089-6
Chimeric antigen receptor-engineered T cells in CLL: the next chapter unfolds
Michael
Kalos
Journal for ImmunoTherapy of Cancer
Dec 2016,
4
(1)
5;
DOI:
10.1186/s40425-016-0108-2
A role for pre-mNK cells in tumor progression
Carolyn
Rosinsky
,
Paul Andrew
Antony
Journal for ImmunoTherapy of Cancer
Dec 2016,
4
(1)
16;
DOI:
10.1186/s40425-016-0120-6
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
next ›
last »
Special collections
COVID-19
(45)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(560)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(983)
Commentary/Editorials
(153)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(56)
Guidelines and Consensus Statements
(53)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(242)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(437)
Liquid Biopsies
(10)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(151)
Reviews
(245)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(5026)
Press releases
(2)
